Client Alerts

On Friday, September 12, 2025, the U.S. Court of Appeals for the Fifth Circuit issued an unpublished decision upholding a Mississippi law that protects 340B contract pharmacy arrangements. The ruling came in [...]

On September 11, 2025, the United States District Court for the Western District of Washington preliminarily stopped the administration’s reinterpretation of the Personal Responsibility and Work Opportunity Reconciliation Act of 1996 (“PRWORA”) [...]

On September 10, 2025, the United States District Court for the District of Rhode Island in State of New York, et al., v. USDOJ, et al., 25-cv-00345 (D.R.I.), granted the States’ Motion [...]

Late last week, the U.S. Department of Health and Human Services (HHS) posted without any fanfare the promised revision to the HHS Grants Policy Statement (GPS), effective October 1, 2025.  This updated [...]

Grantees Must File Separate Cases in U.S. District Court and the Court of Federal Claims The new Administration has rolled out executive orders directing federal agencies to review and terminate grants deemed [...]

On August 12, 2025, the court in State of New York, et al., v. USDOJ, et al., 25-cv-00345 (D. R.I.), entered an updated “Stipulation and Joint Proposal for Briefing Schedule” stating that [...]

“Improving Oversight of Federal Grantmaking” Gives Agency Heads More Control Over Federal Grant Review and Provides for Uniform Guidance Revisions A new Executive Order (EO) issued Thursday, August 7 continues—and expands upon—the [...]

On August 1, 2025, the Office of Pharmacy Affairs (OPA) of the Health Resources and Services Administration (HRSA) announced a pilot rebate program for purchases under the 340B drug discount statute of [...]

In recent months, the Administration has been adding a new condition to Federal awards that ties assurances that grantees comply with long-standing Federal antidiscrimination laws to a requirement that grantees refrain from [...]

DOJ Provides Guidance to Federal Funding Recipients on Unlawful Discrimination In an effort to eliminate the ambiguity over what constitutes “illegal DEI” or “unlawful discrimination,” the U.S. Department of Justice (DOJ) issued [...]